Sort   by:  
 Page size 
UnknownIncreasing lung cancer death rates among young women in southern and midwestern States.
Not available
S-EPMC3402885 | biostudies-literature
UnknownFrom Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.
Not available
S-EPMC4979242 | biostudies-literature
UnknownPhase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324.
Not available
S-EPMC3107747 | biostudies-literature
UnknownDasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
Not available
S-EPMC9882271 | biostudies-literature
UnknownRandomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC4067944 | biostudies-literature
UnknownPhase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma.
Not available
S-EPMC6804828 | biostudies-literature
UnknownSenescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach.
Not available
S-EPMC3926439 | biostudies-literature
UnknownA 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Not available
S-EPMC12820744 | biostudies-literature
UnknownOutcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.
Not available
S-EPMC4076026 | biostudies-literature
UnknownStructural and functional characterization of capsid binding by anti-AAV9 monoclonal antibodies from infants after SMA gene therapy.
Not available
S-EPMC10362397 | biostudies-literature
Sort   by:  
 Page size